ANA SERNA: Open Payments
NPI 1073162798 · EL PASO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$892 in 28 payments from 7 companies in 2025. Trend: 2023 $638 · 2024 $764 · 2025 $892
Food & beverage: $802Education: $90
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $425 |
| GENZYME CORPORATION | 11 | $176 |
| Novartis Pharmaceuticals Corporation | 5 | $113 |
| SANOFI-AVENTIS U.S. LLC | 1 | $56 |
| Regeneron Healthcare Solutions, Inc. | 2 | $50 |
| GlaxoSmithKline, LLC. | 2 | $37 |
| Amgen Inc. | 1 | $34 |
Products named: DUPIXENT, TEZSPIRE, AIRSUPRA, XOLAIR, Rhapsido, TRELEGY ELLIPTA, NUCALA.
Industry payments across TX — which companies pay providers there.
